Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, diarrhoea is a recognised side effect of GLP-1 weight loss injections such as tirzepatide (Mounjaro) and semaglutide (Wegovy). It tends to appear in the first few weeks of treatment or after a dose increase, and for most people it settles as the body adjusts. Understanding why it happens, how to manage it, and when it signals something worth acting on is an important part of starting treatment safely. These are prescription-only medicines that require clinical assessment before a prescriber decides whether they are suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: your pen arrives in a plain, unbranded box, a DPD tracking notification on your phone, a small pre-filled device inside. You start your first dose, and a few days later your digestion feels off. Looser stools, more urgency, maybe some cramping. It is an experience many people have, and it has a straightforward explanation.
Tirzepatide and semaglutide both work partly by slowing gastric emptying, the rate at which food moves from your stomach into the small intestine. That delay is central to how they reduce appetite. But it also means the whole digestive system is adjusting to a different rhythm. The result, for a significant number of people, is a period of GI disruption that can include diarrhoea, nausea, loose stools or an unpredictable bowel pattern. The mechanism behind GI side effects like nausea follows the same pathway.
In the clinical trials for these medicines, gastrointestinal effects were the most commonly reported side effects overall. The NHS tirzepatide medicines page lists diarrhoea as a common side effect, meaning it affects between one in ten and one in one hundred people. Semaglutide carries a similar profile. The good news is that these effects are typically most pronounced early on and after each dose increase; for most people, they reduce meaningfully within two to four weeks as the body adapts.
Eating smaller meals, avoiding high-fat or very spicy food, and drinking enough water through the day all help. Some people find it useful to note which foods seem to make symptoms worse during the adjustment phase.
There is a difference between the inconvenient and the clinically significant. Mild, occasional loose stools that settle within a few weeks sit firmly in the former category. A handful of situations call for a different response.
Persistent or severe diarrhoea can lead to dehydration, and dehydration on a GLP-1 medicine can place strain on the kidneys. Signs worth taking seriously include passing very little urine, dizziness on standing, extreme thirst or a rapid heartbeat. If any of those develop, seek medical advice promptly rather than waiting for the next scheduled check-in.
More urgently: if you experience severe stomach pain that doesn't ease, particularly pain that radiates toward the back, and it is accompanied by vomiting or GI disturbance, get medical help the same day. In January 2026 the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as a known but infrequent serious side effect of GLP-1 medicines, the MHRA Drug Safety Update is worth reading if you want the full clinical detail. Pancreatitis is rare, but the symptom pattern is distinct and should never be written off as ordinary stomach trouble.
Gallbladder problems are another possibility with rapid weight loss in general; symptoms include sharp pain in the upper right abdomen, sometimes with fever or yellowing of the skin. Again, that warrants same-day medical attention. Questions about other serious side effects covered on separate pages address longer-term safety signals in more detail.
Hydration is the most practical lever you have. Aim to replace fluid lost through loose stools, small, frequent sips rather than large glasses if your stomach is already unsettled. Electrolytes can help if diarrhoea is frequent; pharmacies stock rehydration sachets without a prescription, and they are worth keeping at home when you start treatment.
Diet adjustments during the GI adjustment phase are not about restriction, you are already eating less. It is more about composition. Lower-fat meals, smaller portions spread through the day, and less caffeine tend to reduce gut transit speed and ease symptoms. Many people find that the foods triggering diarrhoea early in treatment become tolerable again once the body has adapted.
Physical activity is still encouraged on treatment, but if diarrhoea is acute, high-intensity exercise can worsen dehydration. Listen to your body in that first month.
If symptoms are severe, last more than two to three weeks at a steady dose, or feel disproportionate, tell your prescriber. The titration schedule exists precisely to give your body time to adjust; in some cases slowing the progression makes sense. A prescriber who reviews your case properly (not a one-size algorithm) can make that call. Our clinical team fields questions like this regularly as part of aftercare, seven days a week.
To be direct: most diarrhoea on weight loss injections is uncomfortable but not dangerous. The situations that need prompt attention are dehydration severe enough to affect kidney function, symptoms of pancreatitis (sudden severe back-radiating stomach pain), and signs of a gallbladder problem. If you are ever unsure, calling 111 or your GP is always the right move, no one should talk you out of seeking medical help for a symptom that worries you.
If you experience a side effect you did not expect, or one that seems more severe than the leaflet suggested, you can report it directly via the MHRA Yellow Card scheme. You do not need a referral or a GP appointment to do this. Reports from patients help the MHRA monitor real-world safety data for medicines like these, and the scheme covers suspected counterfeit or substandard products too.
If you are considering starting treatment and want to understand how side effects are discussed and monitored as part of obtaining weight loss injections through a proper assessment, our free consultation is the place to start. A GPhC-registered prescriber reviews every consultation the same day, covering your medical history, any relevant medicines you take, and what to expect. Side effect management is part of that conversation, not an afterthought.
For a broader look at what weight loss injections involve before you reach that point, the weight loss injections overview covers the licensed options available in the UK, including notes on whether B12 injections can contribute to weight loss and whether weight loss injections can cause hair loss.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.